GENTILE, GIORGIO
 Distribuzione geografica
Continente #
NA - Nord America 582
EU - Europa 378
AS - Asia 231
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 1.193
Nazione #
US - Stati Uniti d'America 575
UA - Ucraina 113
IE - Irlanda 94
SG - Singapore 92
IT - Italia 63
VN - Vietnam 57
HK - Hong Kong 50
CN - Cina 27
FI - Finlandia 26
DE - Germania 23
RU - Federazione Russa 20
SE - Svezia 11
GB - Regno Unito 8
CA - Canada 6
AT - Austria 4
CH - Svizzera 4
NL - Olanda 4
CZ - Repubblica Ceca 3
FR - Francia 2
TR - Turchia 2
AU - Australia 1
BE - Belgio 1
EU - Europa 1
GR - Grecia 1
JM - Giamaica 1
KR - Corea 1
PK - Pakistan 1
RS - Serbia 1
UZ - Uzbekistan 1
Totale 1.193
Città #
Chandler 162
Dublin 92
Singapore 82
Jacksonville 70
Dong Ket 56
Hong Kong 50
San Mateo 48
Altamura 36
Boardman 32
Santa Clara 28
Medford 25
Princeton 25
Lawrence 22
Beijing 20
Perugia 20
Wilmington 16
Ann Arbor 8
Andover 7
Norwalk 5
Helsinki 4
New York 4
Seattle 4
Toronto 4
Des Moines 3
London 3
San Paolo di Civitate 3
Amsterdam 2
Ashburn 2
Brno 2
Den Haag 2
Huskvarna 2
Izmir 2
Moscow 2
Saint Petersburg 2
Auburn Hills 1
Belgrade 1
Brisbane 1
Brussels 1
Council Bluffs 1
Dallas 1
Hanoi 1
Hengyang 1
Houston 1
Jianning 1
Lachine 1
Lappeenranta 1
Ottawa 1
Pakistan 1
Pittsburgh 1
Prato 1
Redwood City 1
Seoul 1
Shanghai 1
Tappahannock 1
Vienna 1
Woodbridge 1
Totale 867
Nome #
Beta-blockers and risk of all-cause mortality in non-cardiac surgery. 74
Aliskiren versus ramipril in hypertension. 66
Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and protection from stroke. 60
Choice of ACE inhibitor combinations in hypertensive patients with type 2 diabetes: update after recent clinical trials. 59
Angiotensin-converting enzyme inhibitors 58
Microalbuminuria and hypertension. 57
Day-Night Dip and Early-Morning Surge in Blood Pressure in Hypertension: Prognostic Implications 54
Optimal therapy in hypertensive subjects with diabetes mellitus 53
Blood pressure lowering in diabetic patients. 52
Exploring the optimal combination therapy in hypertensive patients with diabetes mellitus. 51
Diabete Mellito Complicanze Cardiache e Renali (13 Lemmi) 50
Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysis. 50
Effects of intensive blood pressure reduction on myocardial infarction and stroke in diabetes: a meta-analysis in 73,913 patients 49
Pharmacokinetic, pharmacodynamic and clinical evaluation of aliskiren for hypertension treatment. 49
Home Blood Pressure Measurements Will Not Replace 24-Hour Ambulatory Blood Pressure Monitoring. 48
Beyond blood pressure: evidence for cardiovascular, cerebrovascular, and renal protective effects of renin-angiotensin system blockers. 47
Comparative assessment of angiotensin receptor blockers in different clinical settings. 46
Home Blood Pressure Measurements Will or Will Not Replace 24-Hour Ambulatory Blood Pressure Measurement. 44
Telmisartan for the reduction of cardiovascular morbidity and mortality. 44
Tight blood pressure control in diabetes: evidence-based review of treatment targets in patients with diabetes. 44
The 2018 ESC/ESH hypertension guidelines: Should nephrologists always stop at the lower boundary? 44
Vitamin E (Alpha-Tocopherol) Metabolism and Nutrition in Chronic Kidney Disease 37
The voltage of R wave in lead aVL improves risk stratification in hypertensive patients without ECG left ventricular hypertrophy. 35
Role and prognostic value of individual ambulatory blood pressure components in chronic kidney disease 27
Benefits of more intensive versus less intensive blood pressure control. Updated trial sequential analysis 23
Totale 1.221
Categoria #
all - tutte 5.964
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.964


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202063 0 0 0 0 0 0 17 0 20 18 6 2
2020/2021210 0 17 0 17 63 1 19 1 17 1 18 56
2021/2022145 0 25 0 1 6 0 0 59 1 0 27 26
2022/2023410 25 102 4 44 37 41 0 20 118 2 17 0
2023/2024140 9 16 6 1 1 0 24 0 30 2 9 42
2024/2025127 4 28 26 11 42 16 0 0 0 0 0 0
Totale 1.221